Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients - Wikidata - awgldk - TriplyDB

Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients

Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients

http://www.wikidata.org/entity/Q34497220

about

Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations Phosphate control in dialysis Phosphate binders in chronic kidney disease: a systematic review of recent data.Tip-toeing toward the finish line.Phosphorus and nutrition in chronic kidney disease Con: Phosphate binders in chronic kidney disease Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status.Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients.Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial.Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease.A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?A comparative study of the risk profile of hemodialysis patients in a for profit network and in two regional registries of the Italian Society of Nephrology.Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease.Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes.Moderator's view: Phosphate binders in chronic kidney disease patients: a clear 'No' at the moment, but stay tuned.Is serum phosphate a useful target in patients with chronic kidney disease and what is the role for dietary phosphate restriction?Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

P2860

Q26781361-D01C1DD7-6040-4C4B-9E4F-153618983AFB Q27025339-F7E4BFE8-BA78-4E37-A93A-A332AC92CB4F Q31039292-BB360562-C5A4-4BA6-B90F-CAD6E8929C7B Q34865383-B3CF5B89-E796-4E80-8E03-63559BA4C596 Q36014530-16EAA325-14C0-4733-BFC3-2A2BDDF56FC9 Q36497902-08E806BB-8585-406E-9DF5-DCB275DD4D10 Q37512120-2B4D31D6-117A-4A49-BF3D-F02E76C8AEEA Q38202179-B642F20C-7DCA-42E2-ABC3-FEC2B0C0183F Q38219038-CF537F28-D131-423B-8E25-4F219310C453 Q38435719-B97708C3-D9E6-4B3F-9550-5621ABD7AF56 Q38567745-39DBBCBA-8988-47B9-936C-0A4DA9AF9E05 Q38741675-7017DC7E-0F49-4DCB-94FD-00CB70C2BBD5 Q38756817-4F7A420C-7013-4AE3-B1A9-31145567E6C4 Q38837072-4A7C4A24-95CE-4CF6-B580-195D0F1EECCB Q40226740-5ACC0BCE-3959-41FF-A5B0-13B80A0F192E Q41038606-F6F8AF7B-B3A6-4FA1-A09C-C2EC565D59F6 Q52674802-083A32C1-AFA9-4A1F-9400-25279AE8AB48 Q54912272-C99661CE-35FE-4166-8264-DFB6E7559496 Q55476982-699CD2D6-0FE8-4337-9B1D-615EF2972FA7

P2860

Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients

http://www.wikidata.org/entity/Q34497220

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@ast

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@en

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@nl

type

label

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@ast

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@en

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@nl

prefLabel

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@ast

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@en

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@nl

P1433

Q34497220-1BE07408-2077-4CCE-9C78-A90C8DEB4701

P1476

Q34497220-4D3D8AD7-8DDD-4013-840A-0E58478D67EB

P2093

Q34497220-2CEB8678-0F43-4A6A-BF5A-CA1E2668557C

Q34497220-DA4BF858-BC5C-482E-B74D-C0C122644DCC

P2860

Q34497220-035AA3FF-A164-4AAF-8132-974108795147

Q34497220-0DCCDAEA-F948-42E1-A0A5-93D582D72D05

Q34497220-38821233-8A85-456A-88F4-C8035DFED57B

Q34497220-4B6D085A-965A-4AE8-A22E-A3859BE22AD7

Q34497220-519311B7-3362-4EEC-895A-0E3C128FDBA2

Q34497220-5A76F1FF-52C9-463E-AC37-84699B200F90

Q34497220-6C86C6B3-6249-496B-8EBA-0943BF440FCA

Q34497220-A23614F3-BF38-4176-A01A-72AC2A16A622

Q34497220-A4848DE4-6A83-4B91-B388-4138D35141A8

Q34497220-A9045129-45A8-4F73-8D9B-329DEC2E9F89

P304

Q34497220-70B47D9B-5886-4BA5-9778-FCFAF02232DE

P31

Q34497220-9AA863DB-21A3-4C84-8087-A0DF2D445289

P356

Q34497220-1DF4EB27-52B4-4BA9-AEB6-4561ACF6F99F

P433

Q34497220-BE39307A-D3FE-4B88-89B8-368D9B834CD5

P478

Q34497220-4F67349E-BC97-47EC-901E-5EAC26C6020D

P50

Q34497220-2FCA0A91-20A8-47DD-A519-CB0429BF0D8A

P577

Q34497220-1C6447D8-80B3-451F-BEC2-9058D56BAC2E

P698

Q34497220-D669A11E-6448-498F-A761-7F647AE5AA1A

P921

Q34497220-3FA4623E-DA07-4E45-9FF7-47F3DFF62FA2

P932

Q34497220-70430FA5-1531-4A79-ADF5-114F459253EB

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Comparative effectiveness of c ...... ncident U.S. dialysis patients

@en

P2093

Jun Liu

http://www.w3.org/2001/XMLSchema#string

Wolfgang C Winkelmayer

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Phosphorus binders and survival on hemodialysis.

Vascular calcification: in vitro evidence for the role of inorganic phosphate.

Association of serum phosphate with vascular and valvular calcification in moderate CKD.

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia.

Serum phosphate levels and mortality risk among people with chronic kidney disease.

Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

P304

175-183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.05060610

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Bryan R Kestenbaum

P577

2010-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20947790

http://www.w3.org/2001/XMLSchema#string

P921

P932

3022240

http://www.w3.org/2001/XMLSchema#string